CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 539 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02968979
NCT02968979N/ACompleted
CompareCT.gov

Cross-sectional, Multicentric, Non-interventional Study to Assess the Frequency and the Management of Cachexia and Associated Symptoms in Patients With Non-small Cell Lung Cancer.

Chugai Pharma France·observational·Posted Nov 21, 2016·Updated Sep 24, 2019

In Brief

An observational study for Non-small Cell Lung Cancer and Cachexia. Completed, enrolled 539 participants across 1 site.

Detailed Summary

The purpose of this study is to assess the frequency of cachexia and the management of cachexia and associated symptoms in a patient population with non-small cell lung cancer (NSCLC).

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsNon-small Cell Lung Cancer, Cachexia
CountriesFrance
CollaboratorsFrench College of General Hospital Pneumologists (CPHG), French-Speaking Association of Supportive Care in Cancer (AFSOS), ITEC Services

Timeline

N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedNov 21, 2016
Enrollment StartJul 1, 2016
Primary CompletionOct 1, 2016
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 9.6 years ago